Teva Pharmaceuticals To Expand in Canada With $6M Grant
"Teva's high potent product manufacturing facility expansion in Stouffville, Ontario will enable use to secure Canadian and export mandates for high-quality, value-priced generic medicines," said Barry Fishman, president and CEO of Teva Canada Limited. "This partnership with the Ontario government to construct an advanced manufacturing facility will increase Teva Canada's capabilities and capacity and allow us to retain and grow high-value jobs in Ontario."
The same day the expansion was announced, Ontario Premier Dalton McGuinty met with scientists from Israel's Weizman Institute of Science to discuss new partnership opportunities. Among the Institute's research are ways to eliminate famine.
"Teva Pharmaceuticals is a perfect example of the kind of partner we're looking for in Israel," McGuinty said.
Overlook Produce and Farm Adventures Plans Rockingham County, Virginia, Produce Packing Hub
What’s Driving Record Industrial Real Estate Demand
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Pandemic Fuels Data Center Growth
Trends in Office and Industrial Parks
35th Annual Survey of Corporate Executives Commentary: Change in Site Selection Priorities and Plans Over the Short and Long Term